These results supported that BAF312 could inhibit the survival rate of breast cancer by promoting apoptosis of breast cancer cells and decreasing vascular formation of HUVECs via S1PR1/P-STAT3/VEGFA axis. Here, STAT3 is linked to breast carcinoma.